Promoter methylation inhibits APC gene expression by causing changes in chromatin conformation and interfering with

Guoren Deng1, Geun-Am Song, Erik Pong

  • 1Gastrointestinal Research Laboratory, Veteran Affairs Medical Center and Department of Medicine, University of California San Francisco, San Francisco, California, USA.

Cancer Research
|April 17, 2004
PubMed

Insights

DNA methylation silences the APC gene in colorectal cancer by altering chromatin structure and blocking transcription factor binding. This epigenetic silencing is reversible with demethylating agents.

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Cancer Biology

Background:

  • The Adenomatous Polyposis Coli (APC) gene is a key regulator of the Wnt-signaling pathway, crucial for apoptosis and cell cycle control.
  • Loss of APC function, often due to DNA mutations, is implicated in colorectal cancer development.
  • Epigenetic modifications, such as promoter hypermethylation, can also lead to APC gene silencing in various cancers.

Purpose of the Study:

  • To investigate the role of APC promoter methylation in colorectal cancer cell lines.
  • To identify specific regulatory regions within the APC promoter affected by methylation.
  • To elucidate the molecular mechanisms by which APC gene expression is silenced.

Main Methods:

  • Analysis of APC promoter methylation status and gene expression in 22 colorectal cancer cell lines.
  • Nuclease accessibility assays to assess chromatin conformation.
  • Treatment with DNA methyltransferase inhibitor (5-Aza-2'-Deoxycytidine) and histone deacetylase inhibitor (Trichostatin A).
  • Transient transfection assays, electrophoretic mobility shift assays (EMSA), and luciferase reporter assays to study transcription factor binding and gene regulation.

Main Results:

  • Identified Regions A and B in the APC promoter where CpG site methylation correlated with loss of gene expression.
  • Demonstrated that 5-Aza-2'-Deoxycytidine treatment induced APC expression, demethylated CpG sites, and opened chromatin.
  • Showed that methylation around a CCAAT box in Region B inhibited APC expression by preventing CCAAT-binding factor (CBF) binding, confirmed by EMSA and luciferase assays.

Conclusions:

  • APC gene silencing in colorectal cancer is mediated by DNA methylation of CpG sites within the promoter, particularly around the CCAAT box.
  • This methylation alters chromatin conformation and interferes with the binding of transcription factor CBF, leading to gene silencing.
  • The findings highlight the epigenetic regulation of APC and its potential as a therapeutic target.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer is an enzyme that can...